Amyloid-related imaging abnormalities (ARIA): neuroradiologic findings in Alzheimer’s disease patients treated with investigational anti-amyloid therapy
March 23, 2021 | 12:00-1:00 pm ET
The SNMMI Industry Partners Satellite Symposium Series provides a forum for industry partners to directly address the nuclear medicine and molecular imaging community.
Please join our eminent faculty in this complimentary webinar discussing amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease (AD) patients treated with investigational anti-amyloid therapies. We will present an overview of the AD landscape before providing an introduction to ARIA that examines its radiological features and how to detect these events. Through panel discussion, patient case studies will be presented to highlight the key considerations for optimal detection of ARIA and the management steps that could be taken in clinical practice. Following faculty discussions, there will be an opportunity to ask your questions in a live Q&A. We look forward to welcoming you to what promises to be a thought-provoking webinar.
Jerome Barakos, California Pacific Medical Center
Erik Gaensler MD, University of California San Francisco
Stephen Salloway MD, MS, Brown University
No CE will be offered for this webinar.